IRF4 affects the protective effect of regulatory T cells on the pulmonary vasculature of a bronchopulmonary dysplasia mouse model by regulating FOXP3
Authors:
Preprint
- 11 October 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in preterm infants, characterised by compromised alveolar development and pulmonary vascular abnormalities. Emerging evidence suggests that regulatory T cells (Tregs) may confer protective effects on the vasculature. Knockdown of their transcription factor, interferon regulatory factor 4 (IRF4), has been shown to promote vascular endothelial hyperplasia. However, the involvement of Tregs and IRF4 in the BPD pathogenesis remains unclear. This study aimed to investigate the regulation of Tregs by IRF4 and elucidate its potential role in pulmonary vasculature development in a BPD mouse model. Methods The BPD model was established using 85% hyperoxia exposure, with air exposure as the normal control. Lung tissues were collected after 7 or 14 days of air or hyperoxia exposure, respectively. Haematoxylin-eosin staining was performed to assess lung tissue pathology. Immunohistochemistry was used to measure platelet endothelial cell adhesion molecule-1 (PECAM-1) level, flow cytometry to quantify Treg numbers, and Western blot to assess vascular endothelial growth factor (VEGFA), angiopoietin-1 (Ang-1), forkhead box protein P3 (FOXP3), and IRF4 protein levels. We also examined the co-expression of IRF4 and FOXP3 proteins using immunoprecipitation and immunofluorescence double staining. Furthermore, we employed CRISPR/Cas9 technology to knock down the IRF4 gene and observed changes in the aforementioned indicators to validate its effect on pulmonary vasculature development in mice. Results Elevated IRF4 levels in BPD model mice led to FOXP3 downregulation, reduced Treg numbers, and impaired pulmonary vascular development. Knockdown of IRF4 resulted in improved pulmonary vascular development and upregulated FOXP3 level. Conclusion IRF4 may affect the protective role of Tregs in the proliferation of pulmonary vascular endothelial cells and pulmonary vascular development in BPD model mice by inhibiting the FOXP3 level.Keywords
All Related Versions
- Version 1, 2023-10-11, Research Square
- Published version: Molecular Medicine, 30 (1), 1.
This publication has 37 references indexed in Scilit:
- Essential role of interferon regulatory factor 4 (IRF4) in immune cell developmentArchives of Pharmacal Research, 2016
- Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotypeInternational Immunopharmacology, 2016
- Role of Tyk-2 in Th9 and Th17 cells in allergic asthmaScientific Reports, 2014
- Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasiaRespiratory Research, 2013
- Targeting IRF4 in autoimmune diseasesAutoimmunity Reviews, 2012
- Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary HypertensionCirculation Research, 2011
- Transcriptional Regulation of T Helper 17 Cell DifferentiationYonsei Medical Journal, 2010
- IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotypeProceedings of the National Academy of Sciences, 2008
- PECAM-1: A Multi-Functional Molecule in Inflammation and Vascular BiologyArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Bronchopulmonary DysplasiaAmerican Journal of Respiratory and Critical Care Medicine, 2001